Related Experiment Video
Updated: Aug 15, 2026

09:36
Assessment of Child Anthropometry in a Large Epidemiologic Study
Published on: February 2, 2017
Obesity in northern Canadian Indians: patterns, determinants, and consequences
1Department of Community Health Sciences, Faculty of Medicine, University of Manitoba, Winnipeg, Canada.
The American Journal of Clinical Nutrition
|May 1, 1989
Summary
Obesity is highly prevalent in adult Cree and Ojibwa Indians, particularly central obesity. Higher body mass index (BMI) is linked to increased risks of diabetes and hypertension in this population.
Area of Science:
- Indigenous Health
- Public Health Nutrition
- Epidemiology
Background:
- Obesity is a growing global health concern, with significant health disparities observed in Indigenous populations.
- Previous research indicates higher rates of chronic diseases among Indigenous peoples in Canada.
Purpose of the Study:
- To assess the prevalence and characteristics of obesity in adult Cree and Ojibwa populations in northern Canada.
- To identify factors associated with obesity and its relationship with metabolic health indicators and chronic disease risk.
Main Methods:
- Cross-sectional survey of 704 adult Cree and Ojibwa individuals.
- Measurements included body mass index (BMI), skinfold thickness, and girth ratios to assess obesity type.
- Multivariate analyses examined associations between BMI, lifestyle factors, and health outcomes (lipids, blood pressure, glucose).
Main Results:
- High prevalence of obesity across all age-sex groups, with nearly 90% of females aged 45-54 years having a BMI ≥ 26.
- Obesity was predominantly central, indicated by skinfold thickness and girth ratios.
- Obese individuals exhibited higher age-adjusted serum lipids, blood pressure, glucose, and glycosylated hemoglobin, despite lower total energy intake.
- Calorie-adjusted carbohydrate intake was higher in obese subjects.
- Body mass index (BMI) independently predicted diabetic and hypertensive status.
Conclusions:
- Obesity, particularly central obesity, is a major public health issue for Cree and Ojibwa Indians in northern Canada.
- High BMI is a significant risk factor for developing diabetes and hypertension in this population.
- Addressing obesity is critical for preventing future chronic disease burdens in Indigenous communities.
Related Concept Videos
Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Bulimia Nervosa
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

